Neutralizing them reduces SARS-CoV-2–induced mortality in mice, while activating this pathway in cancer with TNF and IFN-g treatment, or IFN and nuclear export inhibitor treatment to modulate ZBP1-ADAR1 regulation for ZBP1-PANoptosome formation, can regress tumors in murine models. This evidence concerns the gene ZBP1 and cancer.